Latest Breaking News On - Oramed pharmaceuticals company profile - Page 1 : comparemela.com

HC Wainwright Weighs in on Oramed Pharmaceuticals Inc s Q3 2024 Earnings (NASDAQ:ORMP)

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Free Report) – Analysts at HC Wainwright decreased their Q3 2024 earnings per share estimates for Oramed Pharmaceuticals in a research report issued on Monday, May 20th. HC Wainwright analyst R. Selvaraju now expects that the biotechnology company will post earnings of ($0.04) per share for the quarter, down from […]

Capital managementOramed pharmaceuticalsNews ratings for oramed pharmaceuticals dailyMurchinson ltdOramed pharmaceuticals company profileOramed pharmaceuticals stockVirtu financialRathbones groupHedge funds weigh in on oramed pharmaceuticalsOramed pharmaceuticals incFree reportOramed pharmaceuticalGet free reportPharmaceuticals incOramed pharmaceuticals daily

HC Wainwright Reiterates Neutral Rating for Oramed Pharmaceuticals (NASDAQ:ORMP)

HC Wainwright Reiterates Neutral Rating for Oramed Pharmaceuticals (NASDAQ:ORMP)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Oramed pharmaceuticals tradingEw advisory servicesOramed pharmaceuticals incInstitutional trading of oramed pharmaceuticalsAlgert globalBarclays plcNews ratings for oramed pharmaceuticals dailyVirtu financialOramed pharmaceuticals company profileOramed pharmaceuticalsFree reportGet free reportAdvisory servicesPharmaceuticals incOramed pharmaceuticals daily

Oramed Pharmaceuticals Inc (NASDAQ:ORMP) Sees Large Increase in Short Interest

Oramed Pharmaceuticals Inc (NASDAQ:ORMP) Sees Large Increase in Short Interest
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Millennium managementOramed pharmaceuticalsOramed pharmaceuticals tradingInstitutional investors weigh in on oramed pharmaceuticalsBlackrock incNews ratings for oramed pharmaceuticals dailyOramed pharmaceuticals company profileOramed pharmaceuticals incGet free reportStreet corpSigma investmentsTwo sigma advisersSigma advisersPharmaceuticals incOramed pharmaceuticals daily

Short Interest in Oramed Pharmaceuticals Inc (NASDAQ:ORMP) Declines By 25 9%

Short Interest in Oramed Pharmaceuticals Inc (NASDAQ:ORMP) Declines By 25 9%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Hong kongOramed pharmaceuticalsRenaissance technologiesOramed pharmaceuticals company profileTower research capitalOramed pharmaceuticals incNews ratings for oramed pharmaceuticals dailyOramed pharmaceuticals price performanceHong kong ltdInstitutional trading of oramed pharmaceuticalsGet free reportKong ltdResearch capitalJacobson investment advisorsPharmaceuticals incOramed pharmaceuticals daily

Oramed Pharmaceuticals Inc (NASDAQ:ORMP) Sees Significant Decrease in Short Interest

Oramed Pharmaceuticals Inc (NASDAQ:ORMP) Sees Significant Decrease in Short Interest
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Belpointe asset managementOramed pharmaceuticals tradingJanney montgomery scottOramed pharmaceuticalsRussell investments group ltdNews ratings for oramed pharmaceuticals dailyOramed pharmaceuticals incOramed pharmaceuticals company profileInstitutional investors weigh in on oramed pharmaceuticalsGet free reportInvestments groupMontgomery scottAsset managementGlass jacobson investment advisorsPharmaceuticals incOramed pharmaceuticals daily